About the Session

Innovation has been at the core of BWH’s mission for over 100 years, from transplant surgery to electronic medical records.  BWH clinicians continue to dream up big ideas in therapeutics, devices, and, increasingly, digital medicine. The Discover Brigham Pitch Session will feature several BWH innovators pitching their most promising ideas to a group of investors, as well as the audience, who will have the chance to ask questions and offer feedback.


This session will be moderated by Jeffrey Greenberg, MD, Assistant Professor at Brigham and Women’s Hospital

9AM – 10AM

Shapiro Breakout Room

[shareaholic app=”share_buttons” id=”18021168″]


Alexander Lin, PhD

Alexander P. Lin, PhD is an assistant professor at Harvard Medical School and director of the Center for Clinical Spectroscopy and Psychiatry Neuroimaging Laboratory at Brigham and Women’s Hospital.  Dr. Lin earned his doctorate in Molecular Biochemistry and Biophysics from the California Institute of Technology.  He has been involved in magnetic resonance spectroscopy since 1997 both from a research and clinical perspective.  The goal of BWH Radiology-iHub project is to bring cutting edge “virtual biopsy” technology to the clinic by developing software that allows radiologist to provide a rapid, non-invasive, and accurate diagnosis of brain tumors.

Ann DeBord Smith MD, MPH

Dr. Ann DeBord Smith General Surgery Resident at Brigham & Women’s Hospital, having recently completed her research fellowship at the Center for Surgery and Public Health at Brigham & Women’s Hospital. Her research is focused on empowering vascular surgery patients by giving them better information to make decisions that are tailored to their own, unique health state. Her research is built on her background in computer science and has included running her own trials to test Eulerian Video Magnification for peripheral perfusion detection, building an app to improve patient/medical team communication around safety issues, using statistical analysis to understand why patients with patent bypass grafts still get amputations, and employing Natural Language Processing to study in-hospital communication between nurses and residents. Her research has been funded by AHRQ. Dr. Smith completed her Masters in Public Health with a focus on Quantitative Methods in 2014 from the Harvard Chan School of Public Health and obtained her MD from University of Chicago Pritzker School of Medicine in 2010. Dr. Louis Nguyen is an active vascular surgeon with an established health services research program and medical informatics. He serves as Director of Vascular Surgery Clinical and Outcomes Research at Brigham & Women’s Hospital (BWH) and Surgery Clinical Lead for Partners eCare. His research has been funded by NIH, AHRQ and the Department of Defense. He mentors clinical and outcomes research fellows in the Harvard-Longwood Vascular Surgery Research T32 training grant and serves as a research mentor to several students, residents and fellows from prominent national and international universities. Dr. Nguyen has served on several national committees, including the Chair of the Comparative Effectiveness Research Committee and member of the Governing Council for the Vascular Quality Initiative for the Society of Vascular Surgery, where he is helping to build the foundations for sustained clinical and outcomes research in vascular surgery. Dr. Nguyen has held a long-standing interest in healthcare and healthcare delivery. Along with his medical degree, he earned a business degree from the University of Chicago where he developed his financial and economic analytical skills. Dr. Nguyen gained additional analytical skills in advanced quantitative methods and clinical trials with his MPH at the Harvard School of Public Health.

Benjamin Raby, MD, MPH

Dr. Benjamin Raby has been working with Drs. Christopher Fanta, Raolat Abdulai and Lakiea Wright on the AIMSpire project. He is Associate Professor of Medicine at the Channing Division of Network Medicine and the Division of Pulmonary and Critical Care Medicine. He is the founder and director of the BWH Pulmonary Genetics Center where he cares for patients with inherited lung diseases. His primary research focuses on combining genomic and computational approaches for the mapping of the genetic determinants of asthma in human populations. His work has been continuously funded by the NIH for the past 13 years, and includes the development of Asthma BRIDGE – the Asthma BioRepository for Integrative Genomics Exploration – multinational effort that established a publicly accessible repository of cell lines and detailed omics datasets from 1,500 asthmatic and healthy subjects to facilitate integrative, systems-based approaches for the study of asthma.

Mark Zhang, DO

Mark Zhang, DO, is a Palliative Care consultant at Dana Farber Cancer Institute and the first Clinical Informatics Fellow at Partners HealthCare.  He completed an Internal Medicine residency and chief year at Allegheny General Hospital in Pittsburgh, PA.  He is a graduate of the Harvard Interprofessional Palliative Care Fellowship.  Throughout his career, Mark has held an interest in leveraging technology to improve clinical medicine.  He is the founder and co-creator of Palliative Care Fast Facts for iOS mobile application.  This application is one of the most popular mobile reference applications in palliative care with an international audience and over seven thousand downloads to date (bit.ly/getfastfacts).  He is also a co-founder of myexitstrategy.co, a 2015 MassChallenge finalist company whose mission is making advance care planning easier and more accessible.  Myexitstrategy.co is working on its first consumer product, CAKE – an app that walks you through matters of life and death (www.joincake.com).